Noble Life Sciences will be attending Bio 2019. Noble is a preclinical CRO providing discovery to GLP safety toxicology studies to support small molecule, biologic, and cell/gene therapy development using a wide variety of in vitro and in vivo preclinical models. With our capabilities spanning from small to large animals, flow cytometry, live animal imaging, we could be your turnkey CRO partners in taking your preclinical program from discovery to IND enabling studies at an accelerated speed.
Srujana Cherukuri, CEO of Noble Life Science will be at Bio 2019 on June 4, 2019. If you are looking for preclinical CRO partner for your oncology, immune-oncology, infectious disease programs, please schedule a meeting through the form on this page.